In Australia medicinal cannabis is not a registered medicine and is not listed on the Australian Register of Therapeutic Good (ARTG). Products not included in the ARTG are referred to as unapproved therapeutic goods. Bedrocan® falls into this category of unapproved therapeutic goods.

Prescribe Bedrocan®

Australian doctors who wish to prescribe Bedrocan® need permission from the Therapeutic Goods Administration (TGA) and the health department of the relevant state or territory. Contact details for the health departments of each Australian state and territory can be found on the Department of Health website.

There are two ways to prescribe Bedrocan®:

• Special Access Scheme (SAS) – an individual patient on a case-by-case basis
• Authorised Prescriber Scheme – multiple patients with the same condition

Special Access Scheme applications can be made online, with approval usually being given within 24–48 hours. More information about these two routes can be found on the Australian Authority’s website. A doctor may also refer a patient to another doctor or clinic that already has experience prescribing cannabis.

NOTE: You must be registered or licensed by the Australian Health Practitioner Regulation Agency (AHPRA) to get access to the online system.

More information

This website provides healthcare professionals with free, evidence-based information about cannabis-based medicines, including administration, dosing and potential drug interactions.